Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1990 Aug;86(2):379–384. doi: 10.1172/JCI114722

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.

A R Tall 1
PMCID: PMC296738  PMID: 2200802

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Applebaum-Bowden D., McLean P., Steinmetz A., Fontana D., Matthys C., Warnick G. R., Cheung M., Albers J. J., Hazzard W. R. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. J Lipid Res. 1989 Dec;30(12):1895–1906. [PubMed] [Google Scholar]
  2. Austin M. A., Breslow J. L., Hennekens C. H., Buring J. E., Willett W. C., Krauss R. M. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988 Oct 7;260(13):1917–1921. [PubMed] [Google Scholar]
  3. BYERS S. O., FRIEDMAN M. Effect of infusions of phosphatides upon the atherosclerotic aorta in situ and as an ocular aortic implant. J Lipid Res. 1960 Jul;1:343–348. [PubMed] [Google Scholar]
  4. Bamberger M., Lund-Katz S., Phillips M. C., Rothblat G. H. Mechanism of the hepatic lipase induced accumulation of high-density lipoprotein cholesterol by cells in culture. Biochemistry. 1985 Jul 2;24(14):3693–3701. doi: 10.1021/bi00335a044. [DOI] [PubMed] [Google Scholar]
  5. Belfrage P., Berg B., Hägerstrand I., Nilsson-Ehle P., Tornqvist H., Wiebe T. Alterations of lipid metabolism in healthy volunteers during long-term ethanol intake. Eur J Clin Invest. 1977 Apr;7(2):127–131. doi: 10.1111/j.1365-2362.1977.tb01584.x. [DOI] [PubMed] [Google Scholar]
  6. Blum C. B., Dell R. B., Palmer R. H., Ramakrishnan R., Seplowitz A. H., Goodman D. S. Relationship of the parameters of body cholesterol metabolism with plasma levels of HDL cholesterol and the major HDL apoproteins. J Lipid Res. 1985 Sep;26(9):1079–1088. [PubMed] [Google Scholar]
  7. Blum C. B., Levy R. I., Eisenberg S., Hall M., 3rd, Goebel R. H., Berman M. High density lipoprotein metabolism in man. J Clin Invest. 1977 Oct;60(4):795–807. doi: 10.1172/JCI108833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brinton E. A., Eisenberg S., Breslow J. L. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J Clin Invest. 1990 Jan;85(1):144–151. doi: 10.1172/JCI114405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brown M. L., Inazu A., Hesler C. B., Agellon L. B., Mann C., Whitlock M. E., Marcel Y. L., Milne R. W., Koizumi J., Mabuchi H. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 1989 Nov 23;342(6248):448–451. doi: 10.1038/342448a0. [DOI] [PubMed] [Google Scholar]
  10. Brown M. S., Goldstein J. L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223–261. doi: 10.1146/annurev.bi.52.070183.001255. [DOI] [PubMed] [Google Scholar]
  11. Busch S. J., Martin G. A., Barnhart R. L., Jackson R. L. Heparin induces the expression of hepatic triglyceride lipase in a human hepatoma (HepG2) cell line. J Biol Chem. 1989 Jun 5;264(16):9527–9532. [PubMed] [Google Scholar]
  12. Chajek T., Eisenberg S. Very low density lipoprotein. Metabolism of phospholipids, cholesterol, and apolipoprotein C in the isolated perfused rat heart. J Clin Invest. 1978 Jun;61(6):1654–1665. doi: 10.1172/JCI109086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cisar L. A., Hoogewerf A. J., Cupp M., Rapport C. A., Bensadoun A. Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation. J Biol Chem. 1989 Jan 25;264(3):1767–1774. [PubMed] [Google Scholar]
  14. Deckelbaum R. J., Eisenberg S., Oschry Y., Butbul E., Sharon I., Olivecrona T. Reversible modification of human plasma low density lipoproteins toward triglyceride-rich precursors. A mechanism for losing excess cholesterol esters. J Biol Chem. 1982 Jun 10;257(11):6509–6517. [PubMed] [Google Scholar]
  15. Glass C., Pittman R. C., Weinstein D. B., Steinberg D. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5435–5439. doi: 10.1073/pnas.80.17.5435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gordon D. J., Rifkind B. M. High-density lipoprotein--the clinical implications of recent studies. N Engl J Med. 1989 Nov 9;321(19):1311–1316. doi: 10.1056/NEJM198911093211907. [DOI] [PubMed] [Google Scholar]
  17. Graham D. L., Oram J. F. Identification and characterization of a high density lipoprotein-binding protein in cell membranes by ligand blotting. J Biol Chem. 1987 Jun 5;262(16):7439–7442. [PubMed] [Google Scholar]
  18. Hesler C. B., Swenson T. L., Tall A. R. Purification and characterization of a human plasma cholesteryl ester transfer protein. J Biol Chem. 1987 Feb 15;262(5):2275–2282. [PubMed] [Google Scholar]
  19. Howell K. E., Palade G. E. Heterogeneity of lipoprotein particles in hepatic Golgi fractions. J Cell Biol. 1982 Mar;92(3):833–845. doi: 10.1083/jcb.92.3.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kiens B., Lithell H. Lipoprotein metabolism influenced by training-induced changes in human skeletal muscle. J Clin Invest. 1989 Feb;83(2):558–564. doi: 10.1172/JCI113918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Krauss R. M. Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease. Am Heart J. 1987 Feb;113(2 Pt 2):578–582. doi: 10.1016/0002-8703(87)90636-3. [DOI] [PubMed] [Google Scholar]
  22. Kuusi T., Kesäniemi Y. A., Vuoristo M., Miettinen T. A., Koskenvuo M. Inheritance of high density lipoprotein and lipoprotein lipase and hepatic lipase activity. Arteriosclerosis. 1987 Jul-Aug;7(4):421–425. doi: 10.1161/01.atv.7.4.421. [DOI] [PubMed] [Google Scholar]
  23. Kuusi T., Saarinen P., Nikkilä E. A. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis. 1980 Aug;36(4):589–593. doi: 10.1016/0021-9150(80)90251-8. [DOI] [PubMed] [Google Scholar]
  24. LeBoeuf R. C., Doolittle M. H., Montcalm A., Martin D. C., Reue K., Lusis A. J. Phenotypic characterization of the Ath-1 gene controlling high density lipoprotein levels and susceptibility to atherosclerosis. J Lipid Res. 1990 Jan;31(1):91–101. [PubMed] [Google Scholar]
  25. Le N. A., Ginsberg H. N. Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol. Metabolism. 1988 Jul;37(7):614–617. doi: 10.1016/0026-0495(88)90077-7. [DOI] [PubMed] [Google Scholar]
  26. Lusis A. J. Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res. 1988 Apr;29(4):397–429. [PubMed] [Google Scholar]
  27. Mahley R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988 Apr 29;240(4852):622–630. doi: 10.1126/science.3283935. [DOI] [PubMed] [Google Scholar]
  28. Manninen V., Elo M. O., Frick M. H., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA. 1988 Aug 5;260(5):641–651. [PubMed] [Google Scholar]
  29. Miller N. E., La Ville A., Crook D. Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit. Nature. 1985 Mar 7;314(6006):109–111. doi: 10.1038/314109a0. [DOI] [PubMed] [Google Scholar]
  30. Nikkilä E. A., Taskinen M. R., Kekki M. Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man. Atherosclerosis. 1978 Apr;29(4):497–501. doi: 10.1016/0021-9150(78)90178-8. [DOI] [PubMed] [Google Scholar]
  31. Olivecrona T., Chernick S. S., Bengtsson-Olivecrona G., Garrison M., Scow R. O. Synthesis and secretion of lipoprotein lipase in 3T3-L1 adipocytes. Demonstration of inactive forms of lipase in cells. J Biol Chem. 1987 Aug 5;262(22):10748–10759. [PubMed] [Google Scholar]
  32. Ong J. M., Kern P. A. Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. J Clin Invest. 1989 Jul;84(1):305–311. doi: 10.1172/JCI114155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Patsch J. R., Karlin J. B., Scott L. W., Smith L. C., Gotto A. M., Jr Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1449–1453. doi: 10.1073/pnas.80.5.1449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pittman R. C., Knecht T. P., Rosenbaum M. S., Taylor C. A., Jr A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. J Biol Chem. 1987 Feb 25;262(6):2443–2450. [PubMed] [Google Scholar]
  35. Quinet E. M., Agellon L. B., Kroon P. A., Marcel Y. L., Lee Y. C., Whitlock M. E., Tall A. R. Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. J Clin Invest. 1990 Feb;85(2):357–363. doi: 10.1172/JCI114446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Semenkovich C. F., Wims M., Noe L., Etienne J., Chan L. Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J Biol Chem. 1989 May 25;264(15):9030–9038. [PubMed] [Google Scholar]
  37. Shepherd J., Packard C. J., Patsch J. R., Gotto A. M., Jr, Taunton O. D. Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest. 1978 Jun;61(6):1582–1592. doi: 10.1172/JCI109078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sloop C. H., Dory L., Hamilton R., Krause B. R., Roheim P. S. Characterization of dog peripheral lymph lipoproteins: the presence of a disc-shaped "nascent" high density lipoprotein. J Lipid Res. 1983 Nov;24(11):1429–1440. [PubMed] [Google Scholar]
  39. Sniderman A. D., Wolfson C., Teng B., Franklin F. A., Bachorik P. S., Kwiterovich P. O., Jr Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med. 1982 Dec;97(6):833–839. doi: 10.7326/0003-4819-97-6-833. [DOI] [PubMed] [Google Scholar]
  40. Sorci-Thomas M., Prack M. M., Dashti N., Johnson F., Rudel L. L., Williams D. L. Apolipoprotein (apo) A-I production and mRNA abundance explain plasma apoA-I and high density lipoprotein differences between two nonhuman primate species with high and low susceptibilities to diet-induced hypercholesterolemia. J Biol Chem. 1988 Apr 15;263(11):5183–5189. [PubMed] [Google Scholar]
  41. Tall A. R., Small D. M. Plasma high-density lipoproteins. N Engl J Med. 1978 Nov 30;299(22):1232–1236. doi: 10.1056/NEJM197811302992207. [DOI] [PubMed] [Google Scholar]
  42. Tall A., Granot E., Brocia R., Tabas I., Hesler C., Williams K., Denke M. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest. 1987 Apr;79(4):1217–1225. doi: 10.1172/JCI112940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Tikkanen M. J., Nikkilä E. A., Kuusi T., Sipinen S. Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activity. Atherosclerosis. 1981 Nov-Dec;40(3-4):365–369. doi: 10.1016/0021-9150(81)90147-7. [DOI] [PubMed] [Google Scholar]
  44. Winkler K. E., Marsh J. B. Metabolism of triglyceride-rich nascent rat hepatic high density lipoproteins. J Lipid Res. 1989 Jul;30(7):989–996. [PubMed] [Google Scholar]
  45. Yano K., Rhoads G. G., Kagan A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med. 1977 Aug 25;297(8):405–409. doi: 10.1056/NEJM197708252970801. [DOI] [PubMed] [Google Scholar]
  46. Yen F. T., Deckelbaum R. J., Mann C. J., Marcel Y. L., Milne R. W., Tall A. R. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest. 1989 Jun;83(6):2018–2024. doi: 10.1172/JCI114112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Zilversmit D. B. Atherogenesis: a postprandial phenomenon. Circulation. 1979 Sep;60(3):473–485. doi: 10.1161/01.cir.60.3.473. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES